Background: Patients without a prior history of diabetes often experience post-operative hyperglycemia after undergoing renal transplantation. Hyperglycemia in the immediate post-transplant period has been associated with increased risk for infection, graft failure and hospital readmission.

Methods: We performed a retrospective review of all adult patients undergoing renal transplantation at a single tertiary referral center from January 1 - December 31, 2019.

Results: Of the 292 patients, 191 (65.2%) did not have a history of diabetes. Of these, 83 (43.5%) were female (mean ±SD age 46.3 ±14.7 years) while 1 (56.5%) were male (mean ±SD age 47.9 ±15.5 years) . The percentage of post-operative days (POD) while hospitalized with any hyperglycemia (≥180 mg/dL) was 55.5% (female 51.8%, male 58.3%) with the highest average blood glucose on POD1 among all patients. The mean±SD point of care (POC) glucose on POD0, 1, 2 and 3 was 123.4±31.5, 151.1±28.6, 139.8±29.7, and 117.4±28.9 mg/dL, respectively (n = 181, 145, 141, and 126 for respective days) . As compared with those without hyperglycemia, patients with any detected hyperglycemia up to POD5 had numerically higher percentage of hospital acquired infection (2.1% vs. 1%) , admission to the intensive care unit (7.9% vs. 3.7%) , and 30-day readmission (20.4% vs. 10.5%) . The percentage of post-operative days with POC glucose <70 mg/dl was 7.9% (female 8.4%, male 7.4%) .

Conclusions: Patients without a history of diabetes who undergo renal transplantation experience hyperglycemia during the majority of days while hospitalized peri-transplant. Further analysis is needed to determine optimal insulin dosing strategies to improve glycemic control in this population.

Disclosure

S.A.Seggelke: None. M.Griff: None. R.Hawkins: None. S.Crawley: None. C.C.Low wang: Employee; CPC Clinical Research, Research Support; CellResearch Corporation, Virta Health Corp.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.